OrthoPediatrics (NASDAQ:KIDS) Earns “Buy” Rating from Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research note issued to investors on Friday, Benzinga reports. The firm currently has a $42.00 price target on the stock.

Several other research firms have also recently weighed in on KIDS. Truist Financial reissued a hold rating and issued a $30.00 price target (down previously from $35.00) on shares of OrthoPediatrics in a research note on Thursday, August 8th. JMP Securities reiterated a market outperform rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research report on Tuesday, May 7th.

OrthoPediatrics Stock Down 1.0 %

NASDAQ KIDS opened at $27.36 on Friday. The business’s fifty day simple moving average is $30.23 and its 200-day simple moving average is $29.73. The company has a quick ratio of 1.99, a current ratio of 4.45 and a debt-to-equity ratio of 0.03. The firm has a market cap of $651.96 million, a PE ratio of -28.50 and a beta of 1.19. OrthoPediatrics has a 52 week low of $23.10 and a 52 week high of $38.99.

Institutional Investors Weigh In On OrthoPediatrics

A number of institutional investors have recently made changes to their positions in KIDS. Deerfield Management Company L.P. Series C purchased a new position in shares of OrthoPediatrics during the 2nd quarter worth approximately $203,000. AQR Capital Management LLC acquired a new position in OrthoPediatrics during the second quarter worth $223,000. Paradigm Capital Management Inc. NY boosted its position in shares of OrthoPediatrics by 8.0% during the second quarter. Paradigm Capital Management Inc. NY now owns 134,400 shares of the company’s stock worth $3,865,000 after buying an additional 10,000 shares during the period. Sei Investments Co. grew its stake in shares of OrthoPediatrics by 345.2% in the second quarter. Sei Investments Co. now owns 30,747 shares of the company’s stock valued at $884,000 after buying an additional 23,841 shares in the last quarter. Finally, Divisadero Street Capital Management LP acquired a new stake in shares of OrthoPediatrics in the second quarter valued at $514,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.